Research output per year
Research output per year
Fingerprint
Dive into the research topics where Julia Maxson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
-
-
-
-
Mechanisms of differentiation blockade in CSF3R-mutant AML
Maxson, J., Maxson, J., Maxson, J. & Maxson, J.
Project: Research project
-
-
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors
Braun, T. P., Estabrook, J., Schonrock, Z., Curtiss, B. M., Darmusey, L., Macaraeg, J., Enright, T., Coblentz, C., Callahan, R., Yashar, W., Taherinasab, A., Mohammed, H., Coleman, D. J., Druker, B. J., Demir, E., Lusardi, T. A. & Maxson, J. E., Feb 2023, In: Leukemia. 37, 2, p. 478-487 10 p.Research output: Contribution to journal › Article › peer-review
-
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5455), 10.1038/s41467-019-13364-2)
Braun, T. P., Okhovat, M., Coblentz, C., Carratt, S. A., Foley, A., Schonrock, Z., Curtiss, B. M., Nevonen, K., Davis, B., Garcia, B., LaTocha, D., Weeder, B. R., Grzadkowski, M. R., Estabrook, J. C., Manning, H. G., Watanabe-Smith, K., Jeng, S., Smith, J. L., Leonti, A. R., Ries, R. E., & 8 others, Dec 2022, In: Nature communications. 13, 1, 3471.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia
Adam, F. C., Szybinski, J., Halter, J. P., Cantoni, N., Wenzel, F., Leonards, K., Brkic, S., Passweg, J. R., Touw, I., Maxson, J. E. & Meyer, S. C., Feb 2022, In: Current Oncology. 29, 2, p. 805-815 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia (Leukemia, (2021), 35, 12, (3594-3599), 10.1038/s41375-021-01278-2)
Carratt, S. A., Braun, T. P., Coblentz, C., Schonrock, Z., Callahan, R., Curtiss, B. M., Maloney, L., Foley, A. C. & Maxson, J. E., Aug 2022, In: Leukemia. 36, 8, p. 2149 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access2 Scopus citations -
Correction to: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia (Leukemia, (2021), 35, 12, (3594-3599), 10.1038/s41375-021-01278-2)
Carratt, S. A., Braun, T. P., Coblentz, C., Schonrock, Z., Callahan, R., Curtiss, B. M., Maloney, L., Foley, A. C. & Maxson, J. E., 2022, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Comment/debate › peer-review
Open Access